期刊文献+

合用丙戊酸钠治疗伴有冲动和攻击行为的精神分裂症的对照研究 被引量:5

下载PDF
导出
摘要 目的:探讨丙戊酸钠合并抗精神病药治疗伴有冲动和攻击行为的精神分裂症的疗效。方法:对60例精神分裂症随机分成两组,一组加用丙戊酸钠(合用组),另一组仍用原抗精神病药物(单用组),治疗8周。采用阳性症状和阴性症状量表(PANSS)、不良反应量表(TESS)评定两组精神症状变化和不良反应。结果:合用组治疗1周后及治疗结束时PANSS量表总分、阳性症状、精神病理症状的评分比单用组明显降低。结论:伴冲动和攻击行为的精神分裂症患者应用丙戊酸钠合并抗精神病药物治疗,起效快,可增加疗效。
作者 王丽君 张静
出处 《中国民康医学》 2010年第5期548-549,共2页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献8

  • 1Brieden M, Naber UD. Psychopharmalogical treatment of aggression in schizophrenic patients [ J ]. Pharmacopsychiatry, 2002,35 : 83 - 89.
  • 2Winterer GW, Hermann M. Valproate and the symptomatic treatment of sehzophrenea spectrum patients [ J ]. Pharmacopsyehiatry, 2003,33 : 182 - 188.
  • 3杨孔军,刘铁榜,杨海晨,高欢,吴东辉,冯征,吴怀安.MECT联合治疗伴兴奋攻击行为的难治性分裂症的对照研究[J].中国民康医学,2005,17(9):485-486. 被引量:7
  • 4梁海翔,杜建艳,吴志江.丙戊酸钠对精神分裂症的辅助治疗作用[J].临床精神医学杂志,2004,14(3):151-152. 被引量:33
  • 5王祖承.精神病学[M].北京:人民卫生出版社,2001..
  • 6Wassef AA, Hafiz NG, Hampton D, et al. Divalproex sodium augmentation of haloperidol in hospitalized patients with schizophrenia: clinical and economic implications [ J ]. J Clin Psychopharmacol, 2001,21:24.
  • 7Goldgerg JF, Citrome I. Latest therapies for bipolar disorder looking beyond lithium [ J ]. Postgrad Med, 2005,117 ( 2 ) :25 - 36.
  • 8Citrome L, Levine J, Allingham B. Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998 [ J ]. Psychiatr Serv,2000,51:636.

二级参考文献11

  • 1[1]Casey DE, Daniel DG, Wassef AA, et al. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia[ J]. Neuropsychopharmacology, 2003,28: 2052.
  • 2[2]Wassef AA, Hafiz NG, Hampton D, et al. Divalproex sodium augmentation of halopefidol in hospitalized patients with schizophrenia: clinical and economic implications[ J ]. J Clin Psychopharmacol, 2001,21: 24.
  • 3[3]Volk D,Austin M, Pierri J, et al. GABA transporter-l mRNA in the prefrontal cortex in schizophrenia:decreased expression in a subset of neurons[ J ]. Am J Psychiatry, 2001,158: 258.
  • 4[4]Reynolds GP,Zhang ZJ,Beasley C.Neuro-chemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity[ J]. Brain Res Bull,2001,55:581.
  • 5[5]Citrome L, Levine J, Allingham B.Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998[J].Psychiatr Serv, 2000,51: 636.
  • 6张作记.行为医学量表手册[J].中国行为医学科学,2001,:118-119.
  • 7Perry PJ,D D Miller, S V Arndt, et al. clozapine and norclozapine plasma concentrations and clinical response of treatment - refractory schizophrenic patients. Am J Psychiatry. 1991,148 (2) :231 -235.
  • 8Jeffrey A Lieberman, Allan Z. Safferman, S. Pollack, et al. Clinical effects of clozapine in chronic schizophrenia response to treatment and predictors of outcome. Am J Psychiatry. 1994,151 (2) :1744 - 1 752.
  • 9刘铁桥,邓云龙.精神分裂症:药物治疗的结局及对策[J].国外医学(精神病学分册),1998,25(3):147-151. 被引量:10
  • 10翟书涛.难治性精神分裂症的发生原因和处理[J].临床精神医学杂志,1998,8(A00):22-25. 被引量:49

共引文献50

同被引文献31

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部